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Because data from one large study of autism1 provided genomic coordinates for an exceptionally small fraction of CNVs
(31 CNVs in 1562 samples) found in affected individuals, we have repeated the analysis summarized in Table 2 from our
recent paper excluding data from that particular study. The new analysis includes CNVs from a total of 10,972 individ-
uals: 5,674 controls as before, but only 5,298 affected individuals as compared to 6,860 in our previous analysis. The
ranking among the top-scoring loci has changed slightly (see Alternate Table 2 below), and p values have uniformly de-
creased (suggesting stronger associations) with two exceptions: duplications at the VCFS locus went from p ¼ 0.330 to
0.454 and duplications overlapping the Terminal 22 del syndrome region went from p ¼ 0.160 to 0.167. The qualitative
conclusions wemade on the basis of the previous analysis and other evidence (that 3q29, 16p12, and 15q25merit further
investigation) have not changed. We believe the new analysis more accurately reﬂects CNV frequencies in individuals
with neurologic disease.
Alternate Table 2. Loci Enriched for CNVs in Autism, Mental Retardation, and Schizophrenia Identified by Disease Meta-analysis











chr15 27,015,263 30,650,000 3,634,737 Prader-Willi/
15q13
yes 19 loss 19 0 S affected
individuals2
9.67E-07




chr22 17,014,900 19,993,127 2,978,227 VCFS yes 30 loss 30 0 A, MR, S affected
individuals2,3,6,7,8
3.14E-10












chr22 45,144,027 49,509,153 4,365,126 Terminal 22
del syndrome
no 4 loss 4 0 A 3,4,6 0.054












chr16 60,141,700 61,581,600 1,439,900 16q21, CDH8 no 4 loss 4 0 A 3 0.054
chr16 60,552,237 61,294,685 742,448 1 gain 1 0 S affected
individuals2
0.483 0.026
chr16 29,470,951 30,252,473 781,522 16p11.2 yes 10 loss 7 3 A,C controls2,4–6 0.145
chr16 29,474,810 30,235,818 761,008 6 gain 5 1 A, S, C affected
individuals2,6,9,c
0.094 0.028
chr11 78,120,000 85,610,000 7,490,000 11q14.1 no 3 loss 3 0 MR, S affected
individuals2,7
0.113
chr11 84,304,683 85,042,205 737,522 1 gain 1 0 S affected
individuals2
0.483 0.054
550 The American Journal of Human Genetics 84, 550–551, April 10, 2009
References
1. Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A., Green, T., et al.
(2008). Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675.
2. International Schizophrenia Consortium. (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia.
Nature 455, 237–241.
3. Autism Genome Project Consortium, Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.Q., Vincent, J.B.,
Skaug, J.L., Thompson,A.P., Senman, L. et al. (2007).Mappingautism risk loci using genetic linkage and chromosomal rearrangements.
Nat. Genet. 39, 319–328.
4. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007).
Strong association of de novo copy number mutations with autism. Science 316, 445–449.
5. Christian, S.L., Brune, C.W., Sudi, J., Kumar, R.A., Liu, S., Karamohamed, S., Badner, J.A., Matsui, S., Conroy, J., McQuaid, D., et al.
(2008). Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol. Psychiatry 63, 1111–1117.
6. Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008).
Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488.
7. de Vries, B.B., Pfundt, R., Leisink, M., Koolen, D.A., Vissers, L.E., Janssen, I.M., Reijmersdal, S., Nillesen, W.M., Huys, E.H., Leeuw, N.,
et al. (2005). Diagnostic genome proﬁling in mental retardation. Am. J. Hum. Genet. 77, 606–616.
8. Xu,B., Roos, J.L., Levy, S., vanRensburg, E.J.,Gogos, J.A., andKarayiorgou,M. (2008). Strongassociationofdenovocopynumbermutations
with sporadic schizophrenia. Nat. Genet. 40, 880–885.
9. Walsh, T., McClellan, J.M., McCarthy, S.E., Addington, A.M., Pierce, S.B., Cooper, G.M., Nord, A.S., Kusenda, M., Malhotra, D.,
Bhandari, A., et al. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science
320, 539–543.
*Correspondence: eee@gs.washington.edu
DOI 10.1016/j.ajhg.2009.03.008. ª2009 by The American Society of Human Genetics. All rights reserved.
Alternate Table 2. Continued











chr2 185,118,087 185,909,729 791,642 2q32.1 no 1 loss 1 0 S affected
individuals2
0.483
chr2 184,270,000 186,892,000 2,622,000 3 gain 3 0 A 3 0.113 0.054
chr15 82,573,421 83,631,697 1,058,276 15q25 yes 4 loss 4 0 A, S affected
individuals2,5,6
0.054
chr15 na na na 0 gain 0 0 none none 1 0.054
chr9 140575 1175526 1,034,951 9p24 no 1 loss 1 0 S affected
individuals2
0.483
chr9 206456 1599250 1,392,794 3 gain 3 0 A, S affected
individuals2,3
0.113 0.054
chr16 21,693,739 22,611,363 917,624 16p12 yes 5b loss 5b 0 A, S affected
individuals2,6
0.026




chr3 197,179,156 198,842,299 1,663,143 3q29 yes 3 loss 3 0 S affected
individuals2,9
0.113




chr16 80,722,684 82,227,917 1,505,233 16q23.3,
CDH13
no 2 loss 0 2 C controls2,c 1
chr16 80,737,839 82,208,451 1,470,612 4 gain 4 0 A, S affected
individuals2,5,9
0.054 0.312
a Indicates whether there are large segmental duplications near breakpoints in hg17.
b A deletion of ~480 kb in size in a schizophrenic sample is included in this count.
C Controls from this study
d A, autism; MR, mental retardation; S, schizophrenia; C, controls.
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